In addition, the analysis of exosomal miRNA from BC cell lines using a Surface-Enhanced Raman Scattering (SERS) sensor confirmed a significantly higher expression of miR-21 in luminal and TNBCs compared to HER2-positive BCs, as previously reported [94]. This evidence concerns the gene ERBB2 and breast cancer.